DNA Extraction Kit Market – Global Outlook & Forecast 2022-2027

DNA Extraction Kit Market – Global Outlook & Forecast 2022-2027

The DNA Extraction Kit market by revenue is expected to grow at a CAGR of 7.7% during 2022-2027.

The center of the genomic revolution is DNA and the IT infrastructure to use it. The impacts are large in the healthcare segment. The recent advancements faster cancer detection, potentially saving thousands of lives globally. Genomic innovations based on DNA have evolved from gene editing to anti-cancer drugs. DNA is widely used as an initial sample for various diagnostics and research purposes. The extraction of DNA is a complex process. After the post introduction of DNA extraction kits, the process is simplified and can be carried out efficiently. The DNA extracted is primarily used to study the genetic cause of the disease, carry out forensic sciences, develop drugs, personalized medicines, paternity tests, and genome sequencing. Genomic advancements are playing a huge role in agricultural biology. They are a significant contributor to plant breeding technology, research like reducing the cost of crop production, and more.

One of the significant benefits is that the RNA/DNA extraction kits are available in various product types for multiple samples. The DNA extraction kit for microbial DNA extractions like Virus, Bacteria. DNA extraction kit for a tissue sample, DNA extraction kit for forensic DNA, Cell-Free DNA extraction kits, and more. This broader portfolio is increasing the end-users count for the DNA extraction kit market.

Technological Advancements are likely to drive the RNA/DNA Extraction Kit Market Growth

The demand for RNA/DNA extraction kits is increasing due to their usage of its applications. The DNA extracted is used in PCR, Genome sequencing, Cloning, and other applications. Increasing demand for this application will drive the demand for DNA Extraction kit market growth. Technological advancements like the introduction of next-generation DNA Extraction kits help the user to isolate the genomic DNA from a range of samples using optimized protocols. This helps the user to obtain high-quality DNA from even specialized samples. This is widely adopted by the researchers to work on multiple samples for the research purpose.

The usage of NGS is increasing in cancer research and personalized treatments. DNA extraction is seen as one of the basic and important steps in NGS library preparation. Increasing demand for personalized medicine, CAR-T therapies, Gene Therapies other regenerative medicines are largely accelerating the usage of DNA extraction kits in the market. In addition, the presence of several research institutes and standalone genomic labs in the developed countries like the US, The UK, Germany are largely involved in the genetic research, genome sequencing, studying genetic characteristics especially the diseased genes in cancer, neurological disorder segments, and other rare genetic diseases are largely driving the usage of the DNA isolation kits in the market.

COVID-19 had a negative impact on the market. The focus was on the RNA Extraction kits, this reduced the usage of DNA extraction kits and not many products were launched during the COVID-19 pandemic. Many genomic research centers were focused to sequence the COVID-19 variants and working for the vaccines. This largely diverted the genomic researchers to shift towards the COVID-19 samples, this largely reduced the DNA-based research or postponed and expected to regain post-COVID-19 pandemic ends.

Geographic Segmentation

North America dominated the DNA extraction kit market share. However, APAC is expected to grow at a faster rate with a CAGR of over 9% in the DNA extraction market. The increasing investments in genome sequencing, increasing adoption of genetic testing-based diagnostics for rare diseases, oncology, and higher adoption of personalized medicines are largely driving the North America Market.

  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East & Africa
THIS RESEARCH REPORT INCLUDE A DETAILED SEGMENTATION ANALYSIS BY:
  • Product Type
  • Application
  • Sample Type
  • End-User
  • Geography
DNA Extraction Kit Market Segmentation Analysis

End-user: The health care facilities having in-house laboratories dominate the end-user segment. The number of samples tested for various genetic diseases, oncology is largely driving the healthcare segment to use the DNA extraction kit.

Sample Type: Blood, Tissue & FFPE samples dominated the sample type segment in the market. Blood, and tissue-based samples are largely used in the diagnostic segment in the market. FFPE samples which are preserved for the biopsy, experimental research, diagnostic, and drug development are large volume of samples that uses the DNA extraction process. These are major contributors to the DNA extraction kit market by sample type in the market.

Product Type: The cell-free DNA accounted for the major part of the product type. However, the genomic DNA segment is growing fast due to increased investments in genomic research and personalized medicines in the market. The Genomic DNA segment is expected to grow at a CAGR of 8.01% in the market.

Applications: PCR application is dominating the applications segment as PCR is a gold standard method to extract the DNA for various study purposes and diagnostics. The sequencing application is increasing significantly as there are technological advancements focused on genomic diagnostics.

Key Vendors
  • Agilent Technologies
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Promega
  • QIAGEN
  • Thermo Fisher Scientific
Other Prominent Vendors
  • 1st BASE
  • 3B BlackBio Biotech India
  • BioChain Institute
  • Bioneer
  • BLIRT
  • Canvax
  • Cell Projects
  • Covaris
  • Cytiva
  • Fivephoton Biochemicals
  • Galenvs Sciences
  • Geneaid Biotech
  • IBI Scientific
  • INVITEK Molecular
  • LabTurbo
  • Lexogen
  • LGC Biosearch Technologies
  • Lucigen
  • MagGenome
  • Merck
  • MP BIOMEDICALS
  • New England Biolabs
  • Omega Bio-tek
  • PCR Biosystems
  • PerkinElmer
  • Primerdesign
  • Takara Bio
  • Vivantis Technologies
  • Xi'an Tianlong Science and Technology
  • Zymo Research
KEY QUESTIONS ANSWERED

1. What will be the size of the global RNA/DNA extraction kit market by 2027?

2. Who are the key players in the DNA extraction kit industry?

3. Which region holds the highest share in the global RNA/DNA extraction kit market?

4. What are the latest trends in the market?

5. Which factors are influencing the DNA extraction kit market growth?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY APPLICATIONS
4.3.3 MARKET SEGMENTATION BY SAMPLE TYPE
4.3.4 MARKET SEGMENTATION BY END-USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.2 MARKET SYNOPSIS
7.2.1 DNA EXTRACTION KITS MARKET OVERVIEW
7.2.2 TECHNOLOGICAL ADVANCES ARE LIKELY TO DRIVE THE DNA EXTRACTION KITS MARKET GROWTH
7.2.3 GEOGRAPHIC SEGMENTATION
8 MARKET OPPORTUNITIES & TRENDS
8.1 AVAILABILITY OF NEXT-GENERATION DNA EXTRACTION KITS
8.2 RISE IN R&D ACTIVITIES IN GENOMICS
8.3 TECHNOLOGICAL ADVANCES IN DNA EXTRACTION KITS
8.4 INCREASE IN GENOMICS & REGENERATIVE MEDICINE PROJECTS
9 MARKET GROWTH ENABLERS
9.1 RISE IN PRODUCT LAUNCHES
9.2 MORE PATIENTS WITH GENETIC DISORDERS
9.3 INCREASED USE OF DNA EXTRACTION KITS IN GENOMICS
10 MARKET RESTRAINTS
10.1 INFLUENCE OF THE COVID-19 PANDEMIC
10.2 LOW PENETRATION OF MOLECULAR & GENOMIC DIAGNOSTICS IN LMICS
10.3 HIGH COST OF DNA EXTRACTION KITS & IMPURE RESULTS
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 GEOGRAPHY INSIGHTS
11.2.2 PRODUCT INSIGHTS
11.2.3 APPLICATIONS INSIGHT
11.2.4 SAMPLE TYPE INSIGHTS
11.2.5 END-USER INSIGHTS
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 PRODUCT
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 CELL-FREE DNA
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 CELL-FREE DNA SEGMENTATION BY GEOGRAPHY
12.4 GENOMIC DNA
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 GENOMIC DNA SEGMENTATION BY GEOGRAPHY
12.5 OTHERS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 OTHERS SEGMENTATION BY GEOGRAPHY
13 APPLICATIONS
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PCR
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 PCR SEGMENTATION BY GEOGRAPHY
13.4 SEQUENCING
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 SEQUENCING SEGMENTATION BY GEOGRAPHY
13.5 CLONING
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 CLONING SEGMENTATION BY GEOGRAPHY
13.6 OTHERS
13.6.1 MARKET OVERVIEW
13.6.2 MARKET SIZE & FORECAST
13.6.3 OTHER APPLICATION SEGMENTATION BY GEOGRAPHY
14 SAMPLE TYPE
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 BLOOD, TISSUE & FFPE
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 BLOOD, TISSUE & FFPE SEGMENTATION BY GEOGRAPHY
14.4 CELLS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 CELLS SEGMENTATION BY GEOGRAPHY
14.5 OTHERS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 OTHER SAMPLE TYPE SEGMENTATION BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 HEALTHCARE FACILITIES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 HEALTHCARE FACILITIES SEGMENTATION BY GEOGRAPHY
15.4 RESEARCH INSTITUTES
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 RESEARCH INSTITUTES BY GEOGRAPHY
15.5 PHARMA & BIOTECH COMPANIES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 PHARMA & BIOTECH COMPANIES BY GEOGRAPHY
15.6 OTHERS
15.6.1 MARKET OVERVIEW
15.6.2 MARKET SIZE & FORECAST
15.6.3 OTHER END-USER SEGMENTATION BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 NORTH AMERICA BY PRODUCT SEGMENTATION
17.2.2 NORTH AMERICA BY APPLICATIONS SEGMENTATION
17.2.3 NORTH AMERICA BY SAMPLE TYPE SEGMENTATION
17.2.4 NORTH AMERICA BY END-USER SEGMENTATION
17.3 KEY COUNTRIES
17.3.1 US: MARKET SIZE & FORECAST
17.3.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 EUROPE BY PRODUCT SEGMENTATION
18.2.2 EUROPE BY APPLICATIONS SEGMENTATION
18.2.3 EUROPE BY SAMPLE TYPE SEGMENTATION
18.2.4 EUROPE BY END-USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 GERMANY: MARKET SIZE & FORECAST
18.3.2 FRANCE: MARKET SIZE & FORECAST
18.3.3 UK: MARKET SIZE & FORECAST
18.3.4 ITALY: MARKET SIZE & FORECAST
18.3.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 APAC BY PRODUCT SEGMENTATION
19.2.2 APAC BY APPLICATIONS SEGMENTATION
19.2.3 APAC BY SAMPLE TYPE SEGMENTATION
19.2.4 APAC BY END-USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 CHINA: MARKET SIZE & FORECAST
19.3.2 JAPAN: MARKET SIZE & FORECAST
19.3.3 INDIA: MARKET SIZE & FORECAST
19.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
19.3.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 LATIN AMERICA BY PRODUCT SEGMENTATION
20.2.2 LATIN AMERICA BY APPLICATIONS SEGMENTATION
20.2.3 LATIN AMERICA BY SAMPLE TYPE SEGMENTATION
20.2.4 LATIN AMERICA BY END-USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 BRAZIL: MARKET SIZE & FORECAST
20.3.2 MEXICO: MARKET SIZE & FORECAST
20.3.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 MIDDLE EAST & AFRICA BY PRODUCT SEGMENTATION
21.2.2 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION
21.2.3 MIDDLE EAST & AFRICA BY SAMPLE TYPE SEGMENTATION
21.2.4 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 TURKEY: MARKET SIZE & FORECAST
21.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.3.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 AGILENT TECHNOLOGIES
22.2.2 BIO-RAD LABORATORIES
22.2.3 F. HOFFMANN-LA ROCHE
22.2.4 PROMEGA
22.2.5 QIAGEN
22.2.6 THERMO FISHER SCIENTIFIC
23 KEY COMPANY PROFILES
23.1 AGILENT TECHNOLOGIES
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 BIO-RAD LABORATORIES
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 F. HOFFMANN-LA ROCHE
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 PROMEGA
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 QIAGEN
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
23.6 THERMO FISHER SCIENTIFIC
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.6.3 KEY STRATEGIES
23.6.4 KEY STRENGTHS
23.6.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 1ST BASE
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 3B BLACKBIO BIOTECH INDIA
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 BIOCHAIN INSTITUTE
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 BIONEER
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 BLIRT
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 CANVAX
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 CELL PROJECTS
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 COVARIS
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 CYTIVA
24.9.1 BUSINESS OVERVIEW
24.9.1 PRODUCT OFFERINGS
24.10 FIVEPHOTON BIOCHEMICALS
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 GALENVS SCIENCES
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 GENEAID BIOTECH
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 IBI SCIENTIFIC
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 INVITEK MOLECULAR
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 LABTURBO
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 LEXOGEN
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 LGC BIOSEARCH TECHNOLOGIES
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 LUCIGEN
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 MAGGENOME
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 MERCK KGAA
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 MP BIOMEDICALS
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 NEW ENGLAND BIOLABS
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 OMEGA BIO-TEK
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 PCR BIOSYSTEMS
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 PERKINELMER
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
24.26 PRIMERDESIGN
24.26.1 BUSINESS OVERVIEW
24.26.2 PRODUCT OFFERINGS
24.27 TAKARA BIO
24.27.1 BUSINESS OVERVIEW
24.27.2 PRODUCT OFFERINGS
24.28 VIVANTIS TECHNOLOGIES
24.28.1 BUSINESS OVERVIEW
24.28.2 PRODUCT OFFERINGS
24.29 XI'AN TIANLONG SCIENCE AND TECHNOLOGY
24.29.1 BUSINESS OVERVIEW
24.29.2 PRODUCT OFFERINGS
24.30 ZYMO RESEARCH
24.30.1 BUSINESS OVERVIEW
24.30.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1.1 PRODUCT
26.1.2 NORTH AMERICA: PRODUCT SEGMENTATION
26.1.3 EUROPE: PRODUCT SEGMENTATION
26.1.4 APAC: PRODUCT SEGMENTATION
26.1.5 LATIN AMERICA: PRODUCT SEGMENTATION
26.1.6 MIDDLE EAST & AFRICA: PRODUCT SEGMENTATION
26.2 APPLICATIONS
26.2.1 NORTH AMERICA: APPLICATIONS SEGMENTATION
26.2.2 EUROPE: APPLICATIONS SEGMENTATION
26.2.3 APAC: APPLICATIONS SEGMENTATION
26.2.4 LATIN AMERICA: APPLICATIONS SEGMENTATION
26.2.5 MIDDLE EAST & AFRICA: APPLICATIONS SEGMENTATION
26.3 MARKET BY SAMPLE TYPE
26.3.1 NORTH AMERICA: SAMPLE TYPE SEGMENTATION
26.3.2 EUROPE: SAMPLE TYPE SEGMENTATION
26.3.3 APAC: SAMPLE TYPE SEGMENTATION
26.3.4 LATIN AMERICA: SAMPLE TYPE SEGMENTATION
26.3.5 MIDDLE EAST & AFRICA: SAMPLE TYPE SEGMENTATION
26.4 END-USER
26.4.1 NORTH AMERICA: END-USER SEGMENTATION
26.4.2 EUROPE: END-USER SEGMENTATION
26.4.3 APAC: END-USER SEGMENTATION
26.4.4 LATIN AMERICA: END-USER SEGMENTATION
26.4.5 MIDDLE EAST & AFRICA: END-USER SEGMENTATION
26.5 GEOGRAPHY
26.5.1 CELL-FREE DNA SEGMENTATION BY GEOGRAPHY
26.5.2 GENOMIC DNA SEGMENTATION BY GEOGRAPHY
26.5.3 OTHERS PRODUCT SEGMENTATION BY GEOGRAPHY
26.5.4 PCR SEGMENTATION BY GEOGRAPHY
26.5.5 SEQUENCING SEGMENTATION BY GEOGRAPHY
26.5.6 CLONING SEGMENTATION BY GEOGRAPHY
26.5.7 OTHER APPLICATION SEGMENTATION BY GEOGRAPHY
26.5.8 BLOOD, TISSUE & FFPE SEGMENTATION BY GEOGRAPHY
26.5.9 CELLS SEGMENTATION BY GEOGRAPHY
26.5.10 OTHER SAMPLE TYPE SEGMENTATION BY GEOGRAPHY
26.5.11 HEALTHCARE FACILITIES SEGMENTATION BY GEOGRAPHY
26.5.12 RESEARCH INSTITUTES SEGMENTATION BY GEOGRAPHY
26.5.13 PHARMA & BIOTECH COMPANIES SEGMENTATION BY GEOGRAPHY
26.5.14 OTHER END-USERS SEGMENTATION BY GEOGRAPHY
27 APPENDIX
27.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings